{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T02:35:57Z","timestamp":1776998157403,"version":"3.51.4"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Diagnosis of invasive candidiasis (IC) is limited by insensitivity and slow turnaround of cultures. Our objectives were to define the performance of T2Candida, a nonculture test, under guidance of a diagnostic stewardship program, and evaluate impact on time to antifungal initiation and antifungal utilization.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a retrospective study of adult medical intensive care unit (MICU) patients with septic shock for whom T2Candida testing was performed from March 2017 to March 2020. Patients with positive T2Candida results during this period were compared to MICU patients who did not undergo T2Candida testing but had septic shock and blood cultures positive for Candida from January 2016 through March 2020.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 155 T2Candida tests from 143 patients were included. Nine percent of T2Candida tests were positive compared to 4.5% of blood cultures. Sensitivity, specificity, positive predictive value, and negative predictive value of T2Candida for proven and probable IC were 78%, 95%, 50%, and 99%, respectively. Patients who tested positive for T2Candida (n = 14) were diagnosed earlier and initiated on antifungal therapy sooner than patients with IC (n = 14) diagnosed by blood culture alone (median, 5.6 vs 60 hours; P &amp;lt; .0001). Median antifungal days of therapy\/1000 patient-days were 23.3\/month preimplementation and 15\/month postimplementation (P \u00a0= .007). Following a negative T2Candida result, empiric antifungals were either not administered in 58% or discontinued within 72 hours in 96% of patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Diagnostic stewardship guided T2Candida testing resulted in reduced time to IC diagnosis, faster initiation of antifungal therapy, and lower antifungal usage among MICU patients with septic shock.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofad538","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T08:43:37Z","timestamp":1699605817000},"source":"Crossref","is-referenced-by-count":12,"title":["Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic Shock"],"prefix":"10.1093","volume":"10","author":[{"given":"Matthew","family":"O\u2019Donnell","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania , USA"},{"name":"Division of Infectious Diseases, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Antibiotic Management Program, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Department of Critical Care Medicine, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9794-5665","authenticated-orcid":false,"given":"Ryan K","family":"Shields","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania , USA"},{"name":"Division of Infectious Diseases, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Antibiotic Management Program, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Department of Pharmacy, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel V","family":"Marini","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Antibiotic Management Program, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Department of Pharmacy, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara M","family":"Groetzinger","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian A","family":"Potoski","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania , USA"},{"name":"Division of Infectious Diseases, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Antibiotic Management Program, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Department of Pharmacy, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie A","family":"Falcione","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania , USA"},{"name":"Division of Infectious Diseases, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Antibiotic Management Program, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Department of Pharmacy, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunish","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Antibiotic Management Program, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Department of Pharmacy, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6705-2225","authenticated-orcid":false,"given":"Erin K","family":"McCreary","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd","family":"Clarke","sequence":"additional","affiliation":[{"name":"Antibiotic Management Program, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Brant","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan J","family":"McVerry","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania , USA"},{"name":"Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Liegey","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A William","family":"Pasculle","sequence":"additional","affiliation":[{"name":"Division of Clinical Microbiology, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Department of Pathology, University of Pittsburgh , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius J","family":"Clancy","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania , USA"},{"name":"Veterans Affairs Pittsburgh Healthcare System , Department of Medicine, Division of Infectious Diseases, Pittsburgh, Pennsylvania , USA {C}%3C!%2D%2D%7C%7CrmComment%7C%7C%3C~show%20%5BAQ%20ID%3DAQ3%5D~%3E%2D%2D%3E"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2065-3239","authenticated-orcid":false,"given":"M Hong","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania , USA"},{"name":"Division of Infectious Diseases, UPMC , Pittsburgh, Pennsylvania , USA"},{"name":"Antibiotic Management Program, UPMC , Pittsburgh, Pennsylvania , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"2023113021483105100_ofad538-B1","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2023113021483105100_ofad538-B2","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2023113021483105100_ofad538-B3","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2023113021483105100_ofad538-B4","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cix1095","article-title":"Detecting infections rapidly and easily for candidemia trial, part 2 (DIRECT2): a prospective, multicenter study of the T2Candida panel","volume":"66","author":"Clancy","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2023113021483105100_ofad538-B5","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12879-019-4419-z","article-title":"Pooled analysis of T2 Candida for rapid diagnosis of candidiasis","volume":"19","author":"Tang","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"Suppl 4","key":"2023113021483105100_ofad538-B6","doi-asserted-by":"crossref","first-page":"iv27","DOI":"10.1093\/jac\/dky046","article-title":"Impact of rapid, culture-independent diagnosis of candidaemia and invasive candidiasis in a community health system","volume":"73","author":"Patch","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2023113021483105100_ofad538-B7","doi-asserted-by":"crossref","first-page":"e01408","DOI":"10.1128\/JCM.01408-19","article-title":"Evaluation of a rapid fungal detection panel for identification of candidemia at an academic medical center","volume":"58","author":"Bomkamp","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2023113021483105100_ofad538-B8","first-page":"12","article-title":"T2 magnetic resonance assay improves timely management of candidemia","volume":"1","author":"Wilson","year":"2017","journal-title":"J Antimicrob Steward"},{"key":"2023113021483105100_ofad538-B9","doi-asserted-by":"crossref","first-page":"115086","DOI":"10.1016\/j.diagmicrobio.2020.115086","article-title":"Utilization and impact of a rapid Candida panel on antifungal stewardship program within a large community hospital","volume":"97","author":"Steuber","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2023113021483105100_ofad538-B10","doi-asserted-by":"crossref","first-page":"dlad035","DOI":"10.1093\/jacamr\/dlad035","article-title":"T2Candida assay: diagnostic performance and impact on antifungal prescribing","volume":"5","author":"Patroc\u00ednio de Jesus","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"2023113021483105100_ofad538-B11","doi-asserted-by":"crossref","first-page":"e01909","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing invasive candidiasis","volume":"56","author":"Clancy","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"Suppl 4","key":"2023113021483105100_ofad538-B12","doi-asserted-by":"crossref","first-page":"iv2","DOI":"10.1093\/jac\/dky050","article-title":"T2 magnetic resonance for the diagnosis of bloodstream infections: charting a path forward","volume":"73","author":"Clancy","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2023113021483105100_ofad538-B13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"2023113021483105100_ofad538-B14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s15010-019-01277-7","article-title":"Derivation of a quick Pitt Bacteremia Score to predict mortality in patients with gram-negative bloodstream infection","volume":"47","author":"Battle","year":"2019","journal-title":"Infection"},{"key":"2023113021483105100_ofad538-B15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/myc.12644","article-title":"The Pitt Bacteremia Score, Charlson Comorbidity Index and Chronic Disease Score are useful tools for the prediction of mortality in patients with Candida bloodstream infection","volume":"60","author":"Vaquero-Herrero","year":"2017","journal-title":"Mycoses"},{"key":"2023113021483105100_ofad538-B16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Le\u00f3n","year":"2006","journal-title":"Crit Care Med"},{"key":"2023113021483105100_ofad538-B17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Ostrosky-Zeichner","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 2","key":"2023113021483105100_ofad538-B18","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023113021483105100_ofad538-B19","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023113021483105100_ofad538-B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"Pt 9","key":"2023113021483105100_ofad538-B21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1099\/jmm.0.019299-0","article-title":"Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies\u2014high frequency of false-positive results and their analysis","volume":"59","author":"Racil","year":"2010","journal-title":"J Med Microbiol"},{"key":"2023113021483105100_ofad538-B22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/CMR.00013-08","article-title":"Candida parapsilosis, an emerging fungal pathogen","volume":"21","author":"Trofa","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"2023113021483105100_ofad538-B23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/clind\/15.3.422","article-title":"Should all patients with candidemia be treated with antifungal agents?","volume":"15","author":"Edwards","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2023113021483105100_ofad538-B24","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/clind\/15.3.414","article-title":"Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality","volume":"15","author":"Fraser","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2023113021483105100_ofad538-B25","doi-asserted-by":"crossref","first-page":"182ra54","DOI":"10.1126\/scitranslmed.3005377","article-title":"T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood","volume":"5","author":"Neely","year":"2013","journal-title":"Sci Transl Med"},{"issue":"1","key":"2023113021483105100_ofad538-B26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cid\/ciw649","article-title":"Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies","volume":"64","author":"Timbrook","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2023113021483105100_ofad538-B27","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2023113021483105100_ofad538-B28","doi-asserted-by":"crossref","first-page":"ofz136","DOI":"10.1093\/ofid\/ofz136","article-title":"Diagnostic performance of T2Candida among ICU patients with risk factors for invasive candidiasis","volume":"6","author":"Arendrup","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2023113021483105100_ofad538-B29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13054-019-2525-3","article-title":"Need for expanded Candida Score for empiric antifungal use in medically critically ill patients?","volume":"23","author":"Laine","year":"2019","journal-title":"Crit Care"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad538\/53046363\/ofad538.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/11\/ofad538\/53898797\/ofad538.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/11\/ofad538\/53898797\/ofad538.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T21:49:12Z","timestamp":1701380952000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad538\/7382081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad538","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,11,1]]},"article-number":"ofad538"}}